ImmunoGen Inc (IMGN):企業の財務・戦略的SWOT分析

◆英語タイトル:ImmunoGen Inc (IMGN) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15899
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

ImmunoGen Inc (IMGN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

ImmunoGen Inc (ImmunoGen) is a clinical-stage biotechnology company that focuses on the development of novel antibody-drug conjugates (ADCs) that facilitate targeted therapies for the treatment of cancer. The company is also advancing a new class of indolino-benzodiazepine deoxy ribonucleic acid (DNA)-acting payload agents, namely IGNs. It is investigating its lead product candidate, mirvetuximab soravtansine in Phase 3 clinical trials; and combination of bevacizumab and pembrolizumab in Phase 2 clinical studies for the treatment of platinum-resistant ovarian cancer. ImmunoGen is investigating IMGN779 in Phase 1 clinical trials for the treatment of acute myeloid leukemia (AML); and IMGN632 for the treatment of AML, and blastic plasmacytoid dendritic cell neoplasm (BPDCN). ImmunoGen is headquartered in Waltham, Massachusetts, the US.

ImmunoGen Inc Key Recent Developments

Mar 01,2019 http://investor.immunogen.com/news-releases/news-release-details/immunogen-announces-top-line-results-phase-3-forward-i-study
Mar 01,2019 ImmunoGen Announces TopLine Results from Phase 3 FORWARD I Study of Mirvetuximab Soravtansine in Ovarian Cancer
Mar 01,2019 ImmunoGen struck by Phase III trial failure in ovarian cancer
Feb 27,2019 ImmunoGen announces multiple presentations at AACR Annual Meeting

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
ImmunoGen Inc – Key Facts
ImmunoGen Inc – Key Employees
ImmunoGen Inc – Key Employee Biographies
ImmunoGen Inc – Major Products and Services
ImmunoGen Inc – History
ImmunoGen Inc – Company Statement
ImmunoGen Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
ImmunoGen Inc – Business Description
R&D Overview
ImmunoGen Inc – Corporate Strategy
ImmunoGen Inc – SWOT Analysis
SWOT Analysis – Overview
ImmunoGen Inc – Strengths
ImmunoGen Inc – Weaknesses
ImmunoGen Inc – Opportunities
ImmunoGen Inc – Threats
ImmunoGen Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
ImmunoGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
ImmunoGen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
ImmunoGen Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 01, 2019: http://investor.immunogen.com/news-releases/news-release-details/immunogen-announces-top-line-results-phase-3-forward-i-study
Mar 01, 2019: ImmunoGen Announces TopLine Results from Phase 3 FORWARD I Study of Mirvetuximab Soravtansine in Ovarian Cancer
Mar 01, 2019: ImmunoGen struck by Phase III trial failure in ovarian cancer
Feb 27, 2019: ImmunoGen announces multiple presentations at AACR Annual Meeting
Feb 08, 2019: ImmunoGen reports recent progress and 2018 operating results
Jan 09, 2019: NIIMBL Announces New Projects to Advance Biopharmaceutical Manufacturing
Nov 26, 2018: ImmunoGen announces resignation of Chief Financial Officer
Nov 26, 2018: ImmunoGen announces resignation of chief financial officer
Nov 02, 2018: ImmunoGen reports recent progress and third quarter 2018 operating results
Oct 20, 2018: ImmunoGen Presents Initial Data from FORWARD II Expansion Cohort Assessing Mirvetuximab Soravtansine in Combination with KEYTRUDA at ESMO 2018 Congress
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
ImmunoGen Inc, Key Facts
ImmunoGen Inc, Key Employees
ImmunoGen Inc, Key Employee Biographies
ImmunoGen Inc, Major Products and Services
ImmunoGen Inc, History
ImmunoGen Inc, Subsidiaries
ImmunoGen Inc, Key Competitors
ImmunoGen Inc, Ratios based on current share price
ImmunoGen Inc, Annual Ratios
ImmunoGen Inc, Annual Ratios (Cont...1)
ImmunoGen Inc, Interim Ratios
ImmunoGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
ImmunoGen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
ImmunoGen Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
ImmunoGen Inc, Performance Chart (2014 - 2018)
ImmunoGen Inc, Ratio Charts
ImmunoGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
ImmunoGen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[ImmunoGen Inc (IMGN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NPO Petrovax Pharm LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary NPO Petrovax Pharm LLC (Petrovax) focuses on the research, development and manufacturing of medicines and vaccines. The company’s expertise spans in producing APIs and liquid, semi-solid, and solid dosage forms in ampoules, plastic containers, vials and disposable syringes. It also provides …
  • Consolidated Edison, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Consolidated Edison, Inc. Merge …
  • Dassault Aviation S.A. (AM):企業概要、財務及び戦略的SWOT分析
    Dassault Aviation S.A. (AM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • The J.M. Smucker Co:戦略・SWOT・企業財務分析
    The J.M. Smucker Co - Strategy, SWOT and Corporate Finance Report Summary The J.M. Smucker Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Persistent Systems Limited (PERSISTENT):企業財務及び戦略的SWOT分析
    Summary Persistent Systems Limited (Persistent) is a software development company that develops and maintains software systems and solutions. The company's software product DNA comprise product concept and design, agile product engineering, performance engineering, professional services, and others. …
  • General Electric Company (GE):企業のM&A・提携動向(エネルギー分野)
    Summary General Electric Company (GE) is an industrial conglomerate. It is a diversified industrial, infrastructure and financial services corporation. The company's product and service portfolio comprises water processing and household appliances to medical imaging, industrial product, business and …
  • A. H. Belo Corporation:企業のM&A・事業提携・投資動向
    A. H. Belo Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's A. H. Belo Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • KPJ Healthcare Berhad (KPJ):企業の財務・戦略的SWOT分析
    Summary KPJ Healthcare Berhad (KPJ) is a healthcare service provider that offers medical services. The center offers services in the areas of anaesthesiology, cardiology and cardiothoracic surgery, child psychiatry, clinic pathology, occupational health services, orthopaedic and trauma surgery, diet …
  • Nuance Communications Inc (NUAN):企業の財務・戦略的SWOT分析
    Nuance Communications Inc (NUAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • TrueBlue, Inc. (TBI):企業概要、財務及び戦略的SWOT分析
    Summary TrueBlue, Inc. (TrueBlue) is staffing service provider. The company offers staffing, recruiting and workforce management services. It recruits individual positions on demand, staffs entire facilities, and manages outsourced recruiting processes and staffing vendor programs for a wide variety …
  • Societe Nationale des Chemins de fer Francais:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Societe Nationale des Chemins d …
  • UniCredit Group:企業の戦略・SWOT・財務分析
    SummaryUniCredit Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Finding …
  • Medical Australia Ltd (MLA)-医療機器分野:企業M&A・提携分析
    Summary Medical Australia Ltd (Medical Australia), formerly BMDi TUTA Healthcare is a medical device company that manufactures and delivers medical devices and equipment for the healthcare industry. The company offers products such as IV systems, safety, blood banking, surgical and anaesthesia produ …
  • Molecular Targeting Technologies, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Molecular Targeting Technologie …
  • National Beef Packing Company LLC.:企業の戦略・SWOT・財務分析
    SummaryNational Beef Packing Company LLC. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the c …
  • Ansaldo Energia S.p.A.:企業のM&A・提携動向(エネルギー分野)
    Summary Ansaldo Energia S.p.A. (Ansaldo Energia) is a supplier of power plant equipments and related services. It offers thermoelectric power plants for independent power producers and industrial clients in Italy and internationally. The company provides power plant equipments such as gas turbines, …
  • ALSO Holding AG:企業の戦略・SWOT・財務情報
    ALSO Holding AG - Strategy, SWOT and Corporate Finance Report Summary ALSO Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Twist Bioscience Corp (TWST):製薬・医療:M&Aディール及び事業提携情報
    Summary Twist Bioscience Corp (Twist Bioscience) is a provider of synthetic DNA Tools. Its silicon-based DNA synthesis platform enables precise synthesis and sequencing process and production of synthetic DNA tools. The company offers its products which include DNA tools for gRNA cloning such as una …
  • Formosa Petrochemical Corporation (6505):企業のM&A・提携動向(石油・ガス分野)
    Summary Formosa Petrochemical Corporation (FPCC) is a petrochemical company. The company operates refinery and integrated petrochemical complexes. It imports, exports, markets, stores, and transports crude oil, gasoline, naphtha, propane and other feed stocks. The company constructs co-generation pl …
  • BankNordik P/F (BNORDIK):企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "BankNordik P/F" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follows a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆